THE USE OF MONOCLONAL ANTIBODIES IN ALLOGENEIC BONE MARROW TRANSPLANTATION

This publication has 31 references indexed in Scilit:

• Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1
  Science, 1992
• T-Lymphocyte-Antigen Interactions in Transplant Rejection
  New England Journal of Medicine, 1990
• Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor Occupancy
  Annual Review of Immunology, 1989
• Manipulation of T-Cell Responses with Monoclonal Antibodies
  Annual Review of Immunology, 1989
• FAILURE OF A CD18/ANTI-LFAl MONOCLONAL ANTIBODY PATIENTS RECEIVING T-DEPLETED ALLOGENEIC BONE INFUSION TO PREVENT GRAFT REJECTION IN LEUKEMIC MARROW TRANSPLANTATION
  Transplantation, 1989
• Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin
  JAMA, 1988
• Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
  The Journal of Experimental Medicine, 1987
• T CELL SUBSETS AND GRAFT-VERSUS-HOST DISEASE
  Transplantation, 1987
• Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease
  Human Immunology, 1984
• Tolerance to histocompatibility determinants in tetraparental bone marrow chimeras.
  The Journal of Experimental Medicine, 1975